Clinical and regulatory events before they become news.
Clinical trials · Drug approvals · Safety & access
Which drugs, companies, trials, and healthcare markets are showing early signs of progress, risk, or change?
Clinical and regulatory records reveal milestones, setbacks, safety signals and access changes as they occur, creating a point-in-time history of drug development and market access.
Which programs are advancing, weakening, or nearing a catalyst?
Trials, FDA filings, disclosures, endpoints, and indications.
When will this read out, and will it slip?
Trial status, enrollment, completion dates, and endpoint changes.
Will this clear the FDA, and on what timeline?
Approvals, CRLs, advisory committees, designations, and labels.
Is this commercially viable, and is a safety signal forming?
CMS and payer decisions, pricing, FAERS, and post-market records.
Expert-grade analysis for the most critical decisions, benchmarked head-to-head against frontier models.
Read the benchmarkApply your lens.
Connect clinical and regulatory events to the drugs, companies, indications and priorities your team follows.
- Clinical trial registries
- FDA actions
- Sponsor disclosures
- Endpoints & indications
- Labels
- Safety records
- Market access decisions
- Payer policies
- Provider datasets
- Hospital financials
- Utilization files
- Post-market obligations
See it running on your desk.
See verified events from the sources, entities and outcomes your team tracks.